SCHEMBL8564623

SCHEMBL8564623

COC(=O)CCC(C)c1cccc(O)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.44
CA7 P43166 1/20 0.44
CA9 Q16790 1/20 0.44
CA14 Q9ULX7 1/20 0.44
HIF1A Q16665 4/20 0.43
ADRB1 P08588 2/20 0.43
ADRA1A P35348 2/20 0.43
ADRB2 P07550 1/20 0.43
HTR1A P08908 1/20 0.43
ADRA2A P08913 1/20 0.43
ADRB3 P13945 1/20 0.43
TSHR P16473 1/20 0.43
ADRA2B P18089 1/20 0.43
ADRA2C P18825 1/20 0.43
NFKB1 P19838 1/20 0.43
DRD1 P21728 1/20 0.43
HTR7 P34969 1/20 0.43
ADRA1B P35368 1/20 0.43
DRD3 P35462 1/20 0.43
RAB9A P51151 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22868040 0.85 CA12 (0.44) CA12CA7CA9CA14LMNA
SCHEMBL2500897 0.84 KCNA5 (0.46) HIF1AADRB1ADRA1AADRB2HTR1A
SCHEMBL2499538 0.84 KCNA5 (0.46) HIF1AADRB1ADRA1AADRB2HTR1A
SCHEMBL15037434 0.84 MEN1 (0.49) CA12CA7CA9CA14ADRB1
SCHEMBL28062736 0.84 KCNA5 (0.48) CA12CA7CA9CA14GAA
SCHEMBL15263361 0.83 HIF1A (0.48) HIF1AADRB1ADRA1AADRB2HTR1A
SCHEMBL4953295 0.82 CA12 (0.52) CA12CA7CA9CA14TSHR
SCHEMBL16034340 0.80 PTGS1 (0.60) CA12CA7CA9CA14HIF1A
SCHEMBL6912280 0.79 ADRB1 (0.50) CA12CA9CA14HIF1AADRB1
SCHEMBL8566584 0.78 MTNR1A (0.46) HIF1ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0544488-B1 Substituted phenyl phenol leukotriene antagonists LILLY CO ELI (US) 1998-03-11 EP disclosed
CN-1035001-C Substituted phenyl phenol leukotriene antagonists LILLY CO ELI (US) 1997-05-28 CN disclosed
WO-1996036347-A1 USE OF LEUKOTRIENE ANTAGONISTS FOR ALZHEIMER'S DISEASE ELI LILLY AND COMPANY (US) 1996-11-21 WO disclosed
EP-0743064-A1 Leukotriene antagonists for use in the treatment or prevention of alzheimer's disease ELI LILLY AND COMPANY (US) 1996-11-20 EP disclosed
US-5462954-A Antiinflammatory, antiallergens; treating asthma ELI LILLY AND COMPANY (US) 1995-10-31 US disclosed
EP-0544488-A2 Substituted phenyl phenol leukotriene antagonists ELI LILLY AND COMPANY (US) 1993-06-02 EP disclosed